Immediate Impact

50 standout
Sub-graph 1 of 25

Citing Papers

The pathophysiology of sepsis and precision-medicine-based immunotherapy
2024 Standout
Lung cancer immunotherapy: progress, pitfalls, and promises
2023 Standout
4 intermediate papers

Works of Ajay Bapna being referenced

Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer That Progressed After Chemotherapy
2011
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer
2011

Author Peers

Author Last Decade Papers Cites
Ajay Bapna 111 74 43 64 36 321
Iwona Homa‐Mlak 69 75 13 62 37 272
Hiroo Imai 160 91 72 106 44 367
Han-Ying Huang 121 27 24 53 29 267
Xiaojie Fang 108 35 26 61 50 301
J Koudstaal 56 77 40 68 26 367
Leszek Kraj 92 64 32 98 28 356
Shweta Agarwal 107 48 95 68 42 357
Yukiko Takahashi 72 75 115 30 34 352
Yoshimi Ishii 130 43 17 48 43 326
Semin Ayhan 76 50 145 47 39 335

All Works

Loading papers...

Rankless by CCL
2026